Colectomy for Cancer in the Elderly by Laparoscopy or Laparotomy
CELL
Multicenter Randomized Trial Comparing Laparoscopy and Laparotomy for Colon Cancer Surgery in Patients Older Than 75 Years
2 other identifiers
interventional
276
1 country
1
Brief Summary
The purpose of this study is to compare the postoperative global morbidity between patients who have been operated on for a colon cancer by laparotomy and those operated on by laparoscopy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 10, 2017
CompletedFirst Posted
Study publicly available on registry
January 27, 2017
CompletedStudy Start
First participant enrolled
July 4, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedJanuary 12, 2018
January 1, 2018
2.7 years
January 10, 2017
January 11, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Global postoperative morbidity in both arms
Postoperative morbidity is defined as any surgical or medical complications occurring up to 30 days after surgery. It will be collected using a standardized collection form during hospitalization and eventual subsequent consultations in case of patient discharge before then
At 30 days after the surgery
Secondary Outcomes (11)
Postoperative mortality
Evaluated at 30 days and at 90 days after the surgery
Rate of readmission
Within the 30 days after discharge of the patient
Number of examined lymph nodes
At surgery
Type of resection (R0 or R1)
At surgery
Pathological evaluation of mesocolic resection quality
At surgery
- +6 more secondary outcomes
Other Outcomes (4)
To establish a specific molecular classification of colon cancer in the elderly from expression chips
within the 15 years after the tumor sampling
To establish associations between molecular subtypes, the clinical and histological factors and relevant genetic alterations
within the 15 years after the tumor sampling
To establish a possible link between these molecular subtypes and overall survival of patients
within the 15 years after the tumor sampling
- +1 more other outcomes
Study Arms (2)
Laparotomy
ACTIVE COMPARATOROpen surgery
Laparoscopy
EXPERIMENTALMinimally invasive surgery
Interventions
Eligibility Criteria
You may qualify if:
- Age ≥ 75 years
- Histologically proven colonic adenocarcinoma (\> 15 cm from the anal margin) or precancerous colonic lesion non endoscopically resectable
- Uncomplicated colonic tumor (no preoperative suspicion of invasion of adjacent structures as assessed by CT-scan (cT4), no tumoral perforation, or tumoral obstruction, or abscess, or hemorrhage)
- No previous colonic cancer within the 5 last years
- No peritoneal carcinosis on CT-scan
- Patient able to fill in an auto-questionnaire alone or with some help
- MMS (Mini Mental Score) ≥ 15
- Given oral consent (formal informed consent is not required by French law for accepted procedures)
You may not qualify if:
- Rectal cancer (≤ 15 cm from the anal margin)
- Locally advanced (cT4) or complicated tumor requiring extended resection or emergency surgery
- Synchronous colonic cancer
- \- Scheduled need for synchronous intra-abdominal surgery, including surgery for liver metastases
- Absolute contraindications to general anesthesia or prolonged pneumoperitoneum
- Patient not able to tolerate colon surgery according to the global comprehensive geriatric assessment
- Estimated life expectancy less than 6 months
- Patient under guardianship
- Other known active cancer (except nonmelanomatous skin cancer)
- Patient not affiliated to the social security system
- Previous colonic resection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Groupe Hospitalier Pitié Salpêtrière
Paris, 75013, France
Related Publications (1)
Manceau G, Brouquet A, Chaibi P, Passot G, Bouche O, Mathonnet M, Regimbeau JM, Lo Dico R, Lefevre JH, Peschaud F, Facy O, Volpin E, Chouillard E, Beyert-Berjot L, Verny M, Karoui M, Benoist S. Multicenter phase III randomized trial comparing laparoscopy and laparotomy for colon cancer surgery in patients older than 75 years: the CELL study, a Federation de Recherche en Chirurgie (FRENCH) trial. BMC Cancer. 2019 Dec 4;19(1):1185. doi: 10.1186/s12885-019-6376-8.
PMID: 31801485DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gilles MANCEAU, M.D., PhD.,
Assistance Publique - Hôpitaux de Paris
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 10, 2017
First Posted
January 27, 2017
Study Start
July 4, 2017
Primary Completion
April 1, 2020
Study Completion
June 1, 2020
Last Updated
January 12, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share